SVB Securities analyst Roanna Ruiz reiterated a Hold rating on Amarin (AMRN – Research Report) yesterday and set a price target of $3.00. The company's shares closed last Thursday at $1.28, close to its 52-week low of $1.11. According to TipRanks.com, Ruiz is ranked 0 out of 5 stars with an average return of -57.2% and a 8.8% success rate. Ruiz covers the Healthcare sector, focusing on stocks such as Enanta Pharmaceuticals, Xeris Pharmaceuticals, and Atea Pharmaceuticals. Amarin has an analyst consensus of Hold, with a price target consensus of $2.80.
https://www.tipranks.com/news/blurbs/amarin-amrn-gets-a-hold-rating-from-svb-securities?utm_source=advfn.com&utm_medium=referral
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Amarin Charts.
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Amarin Charts.